Espínola N, Secco A, Balan D, Kanevsky D, Calvi G, Morisset P, et al. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Rev Peru Med Exp Salud Publica [Internet]. 2024 Jun. 21 [cited 2024 Jul. 2];41(2):129-38. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/12934